<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cancer study</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Breakthrough in how pancreatic cancer cells ingest nutrients points to new drug target</title>
   	 <description>In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options. Pancreatic cancer kills nearly 38,000 Americans annually, making it a leading cause of cancer death. The life expectancy for most people diagnosed with it is less than a year.</description>
     <link>http://medicalxpress.com/news/2013-05-breakthrough-pancreatic-cancer-cells-ingest.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 May 2013 16:47:33 EST</pubDate>
	 <guid isPermaLink="false">news287682443</guid>
	 
</item>
<item>
     <title>Initiation of breast cancer treatment varies by race; patient-doctor communication is key</title>
   	 <description>Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2013-05-breast-cancer-treatment-varies-patient-doctor.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 07 May 2013 12:37:05 EST</pubDate>
	 <guid isPermaLink="false">news287149018</guid>
	 
</item>
<item>
     <title>Taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer, study finds</title>
   	 <description>Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson Cancer Research Center. The findings are published online today in The Prostate.</description>
     <link>http://medicalxpress.com/news/2013-05-cholesterol-lowering-drugs-dying-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 May 2013 10:34:50 EST</pubDate>
	 <guid isPermaLink="false">news286709680</guid>
	 
</item>
<item>
     <title>New genetic clues to breast and ovarian cancer</title>
   	 <description>(Medical Xpress)—A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.</description>
     <link>http://medicalxpress.com/news/2013-05-genetic-clues-breast-ovarian-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 01 May 2013 16:22:24 EST</pubDate>
	 <guid isPermaLink="false">news286644123</guid>
	 
</item>
<item>
     <title>Screening detects ovarian cancer using neighboring cells</title>
   	 <description>Pioneering biophotonics technology developed at Northwestern University is the first screening method to detect the early presence of ovarian cancer in humans by examining cells easily brushed from the neighboring cervix or uterus, not the ovaries themselves.</description>
     <link>http://medicalxpress.com/news/2013-04-screening-ovarian-cancer-neighboring-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 22 Apr 2013 17:10:19 EST</pubDate>
	 <guid isPermaLink="false">news285869412</guid>
	 
</item>
<item>
     <title>Unique study reveals genetic 'spelling mistakes' that increase the risk of common cancers</title>
   	 <description>More than 80 genetic 'spelling mistakes' that can increase the risk of breast, prostate and ovarian cancer have been found in a large, international research study within the framework of the EU Network COGS. For the first time, the researchers also have a relatively clear picture of the total number of genetic alterations that can be linked to these cancers. Ultimately the researchers hope to be able to calculate the individual risk of cancer, to better understand how these cancers develop and to be able to generate new treatments.</description>
     <link>http://medicalxpress.com/news/2013-03-unique-reveals-genetic-common-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 27 Mar 2013 12:07:33 EST</pubDate>
	 <guid isPermaLink="false">news283604832</guid>
	 
</item>
<item>
     <title>Study reveals financial benefits of a plant-based, Mediterranean diet</title>
   	 <description>Researchers from The Miriam Hospital and the Rhode Island Community Food Bank report individuals who participated in a six-week cooking program and followed simple, plant-based recipes decreased their total food spending, purchased healthier food items and improved their food security.</description>
     <link>http://medicalxpress.com/news/2013-03-reveals-financial-benefits-plant-based-mediterranean.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 20 Mar 2013 11:26:15 EST</pubDate>
	 <guid isPermaLink="false">news282997566</guid>
	 
</item>
<item>
     <title>Bitter melon juice prevents pancreatic cancer in mouse models</title>
   	 <description>A University of Colorado Cancer study published this week in the journal Carcinogenesis shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells' energy source and eventually killing them.</description>
     <link>http://medicalxpress.com/news/2013-03-bitter-melon-juice-pancreatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 12 Mar 2013 13:48:12 EST</pubDate>
	 <guid isPermaLink="false">news282314884</guid>
	 
</item>
<item>
     <title>Some men voice complaints of shortened penis following prostate cancer treatment</title>
   	 <description>A small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, with some saying that it interfered with intimate relationships and caused them to regret the type of treatment they chose.</description>
     <link>http://medicalxpress.com/news/2013-01-men-voice-complaints-shortened-penis.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 02 Jan 2013 14:17:49 EST</pubDate>
	 <guid isPermaLink="false">news276358368</guid>
	 
</item>
<item>
     <title>Ability to metabolize tamoxifen affects breast cancer outcomes, study confirms</title>
   	 <description>For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer will recur. A new study by researchers from the Mayo Clinic Cancer Center and the Austrian Breast and Colorectal Cancer Study Group provides evidence that genetic differences in the enzyme CYP2D6 play a key role in how well tamoxifen works.</description>
     <link>http://medicalxpress.com/news/2012-12-ability-metabolize-tamoxifen-affects-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Dec 2012 13:16:43 EST</pubDate>
	 <guid isPermaLink="false">news275836596</guid>
	 
</item>
<item>
     <title>Genes involved in vitamin D generation and destruction may influence colorectal cancer risk in African-Americans</title>
   	 <description>African-Americans are more likely than non-Hispanic whites to have and die from colorectal cancer. Changes in the DNA sequence of genes that affect how the body makes and destroys vitamin D modify the risk for colorectal cancer in African-Americans, according to data presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, held here Oct. 27-30, 2012.</description>
     <link>http://medicalxpress.com/news/2012-10-genes-involved-vitamin-d-destruction.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Oct 2012 10:20:01 EST</pubDate>
	 <guid isPermaLink="false">news270724002</guid>
	 
</item>
<item>
     <title>Two components of red meat combined with alteration in DNA repair increase risk for bladder cancer</title>
   	 <description>Two components of red meat—dietary protein and dietary iron—may combine to form powerful carcinogens, N-nitroso compounds, which increase risk for bladder cancer. Moreover, individuals with reduced ability to reverse the effects of N-nitroso compounds because of a genetic variation in their RAD52 gene could be at particularly high risk.</description>
     <link>http://medicalxpress.com/news/2012-10-components-red-meat-combined-dna.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 17 Oct 2012 15:00:03 EST</pubDate>
	 <guid isPermaLink="false">news269704779</guid>
	 
</item>
<item>
     <title>Daily aspirin may help fight prostate cancer, but not breast cancer</title>
   	 <description>(HealthDay)—Two new studies paint a complex portrait of aspirin's impact on cancer risk and mortality, with one suggesting the drug may lower the risk of dying from prostate cancer and the other seeing no significant drop in the risk for developing breast cancer.</description>
     <link>http://medicalxpress.com/news/2012-08-daily-aspirin-prostate-cancer-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 27 Aug 2012 17:20:02 EST</pubDate>
	 <guid isPermaLink="false">news265303971</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/dailyaspirin.jpg" width="90" height="90" />
</item>
<item>
     <title>Pan-fried meat increases risk of prostate cancer, new study finds</title>
   	 <description>Research from the University of Southern California (USC) and Cancer Prevention Institute of California (CPIC) found that cooking red meats at high temperatures, especially pan-fried red meats, may increase the risk of advanced prostate cancer by as much as 40 percent.</description>
     <link>http://medicalxpress.com/news/2012-08-pan-fried-meat-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Aug 2012 16:40:21 EST</pubDate>
	 <guid isPermaLink="false">news264354012</guid>
	 
</item>
<item>
     <title>Access to clinical trials drives dramatic increases in survival from childhood cancer</title>
   	 <description>More children are surviving cancer in Britain than ever before according to new research published in the cancer journal Annals of Oncology [1] today (Wednesday). The improvement in survival has been driven by the increasing numbers taking part in clinical trials since 1977 when the UK Children's Cancer Study Group (UKCCSG) [2] was established.</description>
     <link>http://medicalxpress.com/news/2012-07-access-clinical-trials-survival-childhood.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 17 Jul 2012 19:30:01 EST</pubDate>
	 <guid isPermaLink="false">news261758728</guid>
	 
</item>
<item>
     <title>Study examines quality of life factors at end of life for patients with cancer</title>
   	 <description>Better quality of life at the end of life for patients with advanced cancer was associated with avoiding hospitalizations and the intensive care unit, worrying less, praying or meditating, being visited by a pastor in a hospital or clinic, and having a therapeutic alliance with their physician, according to a report published Online First by Archives of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-07-quality-life-factors-patients-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 Jul 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261066363</guid>
	 
</item>
<item>
     <title>Research duo say that far too many preclinical cancer study results are just plain wrong</title>
   	 <description>(Medical Xpress) -- C. Glenn Begley, formerly head of cancer research at pharmaceutical giant Amgen and Lee M. Ellis a cancer researcher at the University of Texas, have published a paper together in Nature that is sure to cause a storm of controversy in the cancer research community. They say they have found that more than ninety percent of papers published in science journals describing &quot;landmark&quot; breakthroughs in preclinical cancer research, describe work that is not reproducible, and are thus, just plain wrong.</description>
     <link>http://medicalxpress.com/news/2012-03-duo-preclinical-cancer-results-plain.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 29 Mar 2012 11:09:01 EST</pubDate>
	 <guid isPermaLink="false">news252237692</guid>
	 
</item>
<item>
     <title>Exercise cuts bowel cancer risk</title>
   	 <description>Researchers at the University of Western Australia (UWA) and the Western Australian Institute for Medical Research (WAIMR) have found people who engage in vigorous physical activity may be protected against types of colorectal cancer.</description>
     <link>http://medicalxpress.com/news/2012-01-bowel-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Jan 2012 06:23:10 EST</pubDate>
	 <guid isPermaLink="false">news244880581</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/exercisecuts.jpg" width="90" height="90" />
</item>


</channel>
</rss>
